Diagnostics & Research
The Diagnostics & Research industry has a total of 57 stocks, with a combined market cap of $703.05 billion, total revenue of $158.34 billion and a weighted average PE ratio of 62.13.
Market Cap
703.05B
Revenue
158.34B
Profits
11.32B
PE Ratio
62.13
Profit Margin
7.15%
Dividend Yield
0.22%
57 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 200.45B | 1.42% | 1,417,719 | 42.37B |
| 2 | DHR | Danaher Corporation | 165.08B | 1.06% | 3,954,280 | 23.74B |
| 3 | A | Agilent Technologies, Inc. | 38.42B | 0.99% | 1,372,849 | 6.51B |
| 4 | IQV | IQVIA Holdings Inc. | 35.80B | 3.00% | 3,330,636 | 15.32B |
| 5 | IDXX | IDEXX Laboratories, Inc. | 33.76B | 0.79% | 862,264 | 3.84B |
| 6 | MTD | Mettler-Toledo International Inc. | 25.97B | 2.05% | 122,315 | 3.76B |
| 7 | WAT | Waters Corporation | 21.86B | 2.09% | 473,060 | 2.91B |
| 8 | ILMN | Illumina, Inc. | 21.57B | 1.51% | 14,036,300 | 4.39B |
| 9 | NTRA | Natera, Inc. | 21.37B | 2.40% | 2,760,007 | 1.53B |
| 10 | LH | Labcorp Holdings Inc. | 19.12B | 0.72% | 460,432 | 12.71B |
| 11 | ICLR | ICON Public Limited Company | 17.13B | 1.42% | 703,802 | 8.31B |
| 12 | DGX | Quest Diagnostics Incorporated | 17.09B | 1.04% | 634,918 | 9.54B |
| 13 | RVTY | Revvity, Inc. | 13.70B | 1.83% | 625,745 | 2.72B |
| 14 | EXAS | Exact Sciences Corporation | 10.99B | 5.86% | 2,733,198 | 2.69B |
| 15 | MEDP | Medpace Holdings, Inc. | 10.46B | 0.64% | 558,786 | 2.07B |
| 16 | QGEN | Qiagen N.V. | 9.93B | 0.79% | 760,147 | 1.97B |
| 17 | CRL | Charles River Laboratories International, Inc. | 9.50B | 1.99% | 581,733 | 4.06B |
| 18 | RDNT | RadNet, Inc. | 5.38B | 1.85% | 1,061,752 | 1.77B |
| 19 | GH | Guardant Health, Inc. | 3.91B | 1.73% | 2,088,660 | 692.26M |
| 20 | SHC | Sotera Health Company | 3.75B | -0.23% | 2,332,581 | 1.12B |
| 21 | VCYT | Veracyte, Inc. | 3.17B | 4.66% | 1,680,655 | 425.33M |
| 22 | TWST | Twist Bioscience Corporation | 2.85B | 9.90% | 1,918,845 | 312.97M |
| 23 | NEOG | Neogen Corporation | 2.61B | 0.17% | 3,364,909 | 912.20M |
| 24 | NEO | NeoGenomics, Inc. | 2.11B | 0.06% | 1,781,858 | 644.12M |
| 25 | MYGN | Myriad Genetics, Inc. | 1.22B | 1.44% | 3,028,694 | 823.60M |
| 26 | CDNA | CareDx, Inc | 1.11B | 0.29% | 1,650,928 | 312.78M |
| 27 | OPK | OPKO Health, Inc. | 1.04B | -1.91% | 4,228,248 | 711.41M |
| 28 | CSTL | Castle Biosciences, Inc. | 771.04M | 1.62% | 368,127 | 311.88M |
| 29 | GRAL | GRAIL, Inc. | 616.57M | 7.06% | 3,350,795 | 117.67M |
| 30 | FLGT | Fulgent Genetics, Inc. | 560.96M | -2.19% | 610,089 | 277.76M |
| 31 | PSNL | Personalis, Inc. | 406.23M | 9.32% | 8,014,649 | 87.49M |
| 32 | ACRS | Aclaris Therapeutics, Inc. | 291.00M | -1.81% | 1,156,054 | 27.08M |
| 33 | BDSX | Biodesix, Inc. | 228.38M | 15.44% | 738,310 | 65.56M |
| 34 | MDXH | MDxHealth SA | 106.87M | 4.63% | 104,865 | 84.71M |
| 35 | NOTV | Inotiv, Inc. | 106.14M | 6.25% | 1,239,800 | 490.74M |
| 36 | FONR | FONAR Corporation | 96.89M | 0.20% | 8,343 | 102.01M |
| 37 | XGN | Exagen Inc. | 90.83M | 9.34% | 77,361 | 55.75M |
| 38 | ME | 23andMe Holding Co. | 84.49M | 6.86% | 295,598 | 193.26M |
| 39 | PRE | Prenetics Global Limited | 68.97M | 2.64% | 10,442 | 25.56M |
| 40 | BNR | Burning Rock Biotech Limited | 67.50M | 6.99% | 13,762 | 72.83M |
| 41 | VNRX | VolitionRx Limited | 62.63M | 16.33% | 401,292 | 1.29M |
| 42 | STIM | Neuronetics, Inc. | 42.18M | 7.75% | 95,929 | 72.71M |
| 43 | ENZ | Enzo Biochem, Inc. | 39.85M | 7.05% | 433,912 | 30.31M |
| 44 | OCX | OncoCyte Corporation | 36.87M | -0.91% | 51,388 | 709.00K |
| 45 | BIAF | bioAffinity Technologies, Inc. | 15.47M | -15.86% | 476,156 | 9.37M |
| 46 | PRPH | ProPhase Labs, Inc. | 14.58M | -6.52% | 319,202 | 12.75M |
| 47 | AWH | Aspira Women's Health Inc. | 12.83M | 0.65% | 85,105 | 8.96M |
| 48 | APDN | Applied DNA Sciences, Inc. | 9.26M | -5.29% | 4,644,809 | 3.43M |
| 49 | XWEL | XWELL, Inc. | 8.41M | 8.11% | 57,716 | 33.83M |
| 50 | PRPO | Precipio, Inc. | 7.81M | -3.30% | 2,597 | 17.41M |
| 51 | TTOO | T2 Biosystems, Inc. | 7.37M | 4.76% | 476,623 | 7.68M |
| 52 | STRR | Star Equity Holdings, Inc. | 6.95M | -1.82% | 21,123 | 50.38M |
| 53 | MYNZ | Mainz Biomed N.V. | 4.27M | 40.04% | 660,400 | 917.20K |
| 54 | CHEK | Check-Cap Ltd. | 3.45M | 3.45% | 32,002 | - |
| 55 | NDRA | ENDRA Life Sciences Inc. | 2.96M | 2.61% | 52,751 | - |
| 56 | ISPC | iSpecimen Inc. | 2.89M | 1.35% | 2,418,868 | 10.39M |
| 57 | FRES | Fresh2 Group Limited | 2.49M | -5.08% | 7,839 | 2.34M |